MGEN - Viridian Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Viridian Therapeutics's activity chart (see below) currently has 6 price targets and 12 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 170.67 days.

Most recent stock forecast was given by LELAND GERSHELL from OPPENHEIMER on 31-Dec-2020. First documented stock forecast 21-Feb-2017.

Best performing analysts who are covering MGEN - Viridian Therapeutics:

Leland Gershell Liana Moussatos Madhu Kumar

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 21-Mar-2019

$37

$19 (105.56%)

$12

5 years 8 months 29 days ago
(31-Dec-2020)

1/2 (50%)

$20.55 (124.92%)

189

Buy Since 21-Feb-2017

$15

$-3 (-16.67%)

5 years 11 months 23 days ago
(06-Oct-2020)

1/2 (50%)

$6.28 (72.02%)

22

Buy Since 25-Jul-2017

6 years 9 months 17 days ago
(12-Dec-2019)

1/2 (50%)

$-37.7 (-79.04%)

301

Show more analysts

Please expand the browser size to see the chart

What is MGEN (Viridian Therapeutics) average time for price targets to be met?

On average it took 171 days for the stock forecasts to be reached, with an average price target met ratio of 50%.

Which analyst most recently updated their price target on MGEN (Viridian Therapeutics)?

Leland Gershell

Which analyst has the most public recommendations on MGEN (Viridian Therapeutics)?

Leland Gershell works at OPPENHEIMER and has 20 price targets and 12 ratings on MGEN

Which analyst is the currently most bullish on MGEN (Viridian Therapeutics)?

Leland Gershell with the highest potential upside of $19

Which analyst is the currently most reserved on MGEN (Viridian Therapeutics)?

Liana Moussatos with the lowest potential downside of -$3
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?